1. Contrast-Enhanced Ultrasound in the Differential Diagnosis of Exocrine Versus Neuroendocrine Pancreatic Tumors
- Author
-
Maria Luigia Cipollini, Elena Mazzotta, Roberto De Giorgio, Riccardo Casadei, Paola Tomassetti, Cristina Felicani, Lydia Piscitelli, Antonio Maria Morselli-Labate, Vincenzo Stanghellini, Roberto Corinaldesi, Raffaele Pezzilli, Carla Serra, Serra C, Felicani C, Mazzotta E, Piscitelli L, Cipollini ML, Tomassetti P, Pezzilli R, Casadei R, Morselli-Labate AM, Stanghellini V, Corinaldesi R, and De Giorgio R
- Subjects
Adult ,Male ,medicine.medical_specialty ,DIAGNOSTIC ACCURACY ,CEUS ,pancreatic masses ,pancreatic ductal carcinoma ,contrast-enhanced ultrasound ,Ultrasonography ,endocrine pancreatic tumors ,exocrine pancreatic tumors ,neuroendocrine pancreatic tumors ,Endocrinology, Diabetes and Metabolism ,Contrast Media ,Diagnostic accuracy ,NO ,Diagnosis, Differential ,Endocrinology ,Internal Medicine ,Humans ,Medicine ,Endocrine system ,Prospective Studies ,Endocrine pancreatic tumors ,pancreatic masse ,Prospective cohort study ,Aged ,Aged, 80 and over ,exocrine pancreatic tumor ,Hepatology ,business.industry ,Ultrasound ,endocrine pancreatic tumor ,Reproducibility of Results ,Middle Aged ,Image Enhancement ,Pancreas, Exocrine ,Pancreatic Neoplasms ,Neuroendocrine Tumors ,medicine.anatomical_structure ,ROC Curve ,Female ,Radiology ,Differential diagnosis ,business ,Pancreas ,Contrast-enhanced ultrasound - Abstract
OBJECTIVES: Contrast-enhanced ultrasound (CEUS) has been developed to better characterize the microvasculature of solid masses in several organs, including the pancreas. In this study, we assessed CEUS accuracy in differentiating exocrine from endocrine pancreatic tumors. METHODS: A total of 127 patients with single, undetermined pancreatic masses were prospectively examined with transabdominal ultrasound and CEUS, before surgical resection or percutaneous biopsy. RESULTS: Exocrine and endocrine pancreatic tumors showed different intralesional vascularization patterns: 98.9% (90/91) of exocrine tumors were hypoenhancing, whereas 95.8 % (23/24) of endocrine tumors had a hypervascular supply. A hypoenhancing pattern, indicative of ductal adenocarcinoma, had a significant (P < 0.001) diagnostic accuracy of 91.3% with a sensitivity of 96.8%, a specificity of 85.3%, a positive predictive value and a negative predictive value of 94.7% and 90.6%, respectively. The hyperenhancing pattern, indicative of endocrine tumors, had a significant (P = 0.031) diagnostic accuracy of 73.8% with a sensitivity of 83.3%, a specificity of 60.0%, a positive predictive value and negative predictive value of 83.3% and 60.0%, respectively. CONCLUSIONS: Contrast-enhanced ultrasound has a valuable diagnostic accuracy in differentiating exocrine from endocrine pancreatic tumors, which is a fundamental step to address appropriate histological evaluation, therapeutic approach, and follow-up.
- Published
- 2013
- Full Text
- View/download PDF